Literature DB >> 7862418

Dry eye with only decreased tear break-up time is sometimes associated with allergic conjunctivitis.

I Toda1, J Shimazaki, K Tsubota.   

Abstract

PURPOSE: The authors' clinical experience has suggested that there is a form of dry eye with only decreased tear break-up time, which is associated with allergic conjunctivitis. The current study was performed to verify this hypothesis.
METHOD: The authors recruited patients with two types of dry eye syndrome, those with only decreased tear break-up (BUT type) and those with positive vital staining (staining type). Individuals without any symptoms or signs served as controls. All subjects were compared regarding symptoms, Schirmer and tear clearance test results, conjunctival papillary formation, antigen-specific serum-IgE level (s-IgE), and goblet cell density of the palpebral conjunctiva. Antigen-induced allergic conjunctivitis was produced in guinea pigs, and histopathologic changes of the conjunctiva were examined.
RESULTS: Patients with the BUT-type dry eye syndrome were younger and their symptoms were as severe as the staining type. The Schirmer and tear clearance test results were better, and the papillary formation and s-IgE were observed more than in the BUT type. The average goblet cell density in the BUT-type syndrome was 625.4 +/- 193.2/mm2, which was significantly less than 1005.6 +/- 294.5/mm2 in the controls (P < 0.01). The average goblet cell density was significantly decreased in the allergic animals (10.40 +/- 1.11/0.2 mm) compared with that of the controls (16.21 +/- 0.26/0.2 mm) or the anti-allergic drug-treated group (13.69 +/- 0.30/0.2 mm) (P < 0.01).
CONCLUSION: These results support the authors' hypothesis that decreased break-up time is in part associated with the decreased goblet cell density caused by allergic conjunctivitis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7862418     DOI: 10.1016/s0161-6420(95)31024-x

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  44 in total

1.  Dry eye and Meige's syndrome.

Authors:  K Tsubota; T Fujihara; M Kaido; A Mori; M Mimura; M Kato
Journal:  Br J Ophthalmol       Date:  1997-06       Impact factor: 4.638

Review 2.  Eye complaints in the office environment: precorneal tear film integrity influenced by eye blinking efficiency.

Authors:  P Wolkoff; J K Nøjgaard; P Troiano; B Piccoli
Journal:  Occup Environ Med       Date:  2005-01       Impact factor: 4.402

3.  [Analysis of ocular surface alterations following proton beam radiation in eyes with conjunctival malignant melanoma].

Authors:  H Westekemper; G Anastassiou; W Sauerwein; P Chauvel; N Bornfeld; K-P Steuhl; D Meller
Journal:  Ophthalmologe       Date:  2006-07       Impact factor: 1.059

4.  Tear film mucins: front line defenders of the ocular surface; comparison with airway and gastrointestinal tract mucins.

Authors:  Robin R Hodges; Darlene A Dartt
Journal:  Exp Eye Res       Date:  2013-08-14       Impact factor: 3.467

5.  Association between allergic conjunctivitis and provisional tic disorder in children.

Authors:  Lin Chen; Xinke Chen; Ning Ke; Lianhong Pi; Qing Liu
Journal:  Int Ophthalmol       Date:  2019-09-29       Impact factor: 2.031

6.  Diseases associated with ocular surface abnormalities: the importance of reflex tearing.

Authors:  K Tsubota; M Kaido; Y Yagi; T Fujihara; S Shimmura
Journal:  Br J Ophthalmol       Date:  1999-01       Impact factor: 4.638

7.  Association of contact lens-related allergic conjunctivitis with changes in the morphology of meibomian glands.

Authors:  Reiko Arita; Kouzo Itoh; Shuji Maeda; Koshi Maeda; Atsuo Tomidokoro; Shiro Amano
Journal:  Jpn J Ophthalmol       Date:  2011-11-23       Impact factor: 2.447

8.  New treatment of dry eye: the effect of calcium ointment through eyelid skin delivery.

Authors:  K Tsubota; Y Monden; Y Yagi; E Goto; S Shimmura
Journal:  Br J Ophthalmol       Date:  1999-07       Impact factor: 4.638

9.  Treatment of dry eye by autologous serum application in Sjögren's syndrome.

Authors:  K Tsubota; E Goto; H Fujita; M Ono; H Inoue; I Saito; S Shimmura
Journal:  Br J Ophthalmol       Date:  1999-04       Impact factor: 4.638

Review 10.  Current and Emerging Therapeutic Strategies for the Treatment of Meibomian Gland Dysfunction (MGD).

Authors:  Adam R Thode; Robert A Latkany
Journal:  Drugs       Date:  2015-07       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.